Drawing for NUTRA-CELL INNOVATIONS

USPTO serial 86817592

NUTRA-CELL INNOVATIONS

Reviewed by CopyMark Law Group

Reg. 5162197Status 713
Filing date
Status date
Registration date
Mar 14, 2017
Examiner
WRIGHT, MARCO JABBAR
Law office
TTAB

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NUTRA-CELL INNOVATIONS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Dietary and nutritional supplements used for weight loss; Dietary supplements in the nature of weight loss powders; Herbal topical creams, gels, salves, sprays, powder, balms, liniment and ointments for the relief of aches and pain; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Multi-vitamin preparations; Protein supplement shakes for weight gain purposes; Protein supplements; Therapeutic spray to sooth and relax the muscles; Whey protein supplements; Dried fruits in powder form sold as an ingredient in dietary and nutritional supplements used for weight loss; Dried vegetables in powder form sold as an ingredient in dietary and nutritional supplements used for weight lossSECTION 18 - CANCELLEDOct 18, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 19, 2018C18.CANCELLED SECTION 18-TOTAL—
May 19, 2018CANTCANCELLATION TERMINATED NO. 999999—
May 16, 2018CANGCANCELLATION GRANTED NO. 999999—
Jan 10, 2018PETCCANCELLATION INSTITUTED NO. 999999—
Mar 14, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 4, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 3, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 2, 2017XAECEXAMINER'S AMENDMENT ENTERED—
Feb 2, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 2, 2017GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 2, 2017SNEASU-EXAMINER'S AMENDMENT WRITTEN—
Jan 13, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 5, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 9, 2016IUAFUSE AMENDMENT FILED—
Dec 9, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 9, 2016EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 14, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 19, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 19, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 30, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 8, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 7, 2016DOCKASSIGNED TO EXAMINER—
Nov 17, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 16, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance